NCAPD3 promotes prostate cancer progression by up-regulating EZH2 and MALAT1 through STAT3 and E2F1

被引:19
作者
Jing, Zuolei [1 ]
Liu, Qianmei [1 ]
Xie, Wanlin [1 ]
Wei, Yong [2 ]
Liu, Jiale [1 ]
Zhang, Yi [1 ]
Zuo, Wenren [2 ]
Lu, Shan
Zhu, Qingyi [3 ,4 ]
Liu, Ping [1 ,5 ]
机构
[1] Nanjing Normal Univ, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China
[2] Nanjing Univ Chinese Med, Dept Urol, Nanjing 210023, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Dept Urol, Affiliated Hosp 2, Nanjing 210011, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Dept Urol, Affiliated Hosp 2, 121 Jiangjiayuan, Nanjing 210011, Jiangsu, Peoples R China
[5] Nanjing Normal Univ, Coll Life Sci, 1 Wenyuan Rd, Nanjing 210023, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
NCAPD3; Prostate cancer; EZH2; MALAT1; STAT3; NONCODING RNA MALAT-1; ANDROGEN RECEPTOR; PROTEIN EZH2; POLYCOMB; EXPRESSION; RESISTANT; METASTASIS; TRANSCRIPTION; ACTIVATION; CONDENSIN;
D O I
10.1016/j.cellsig.2022.110265
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
NCAPD3 is one of the non-SMC regulatory subunits of Condensin II, which is mainly responsible for the condensation and segregation of chromosomes during mitosis. However, its role in cancer especially in prostate cancer (PCa) and the molecular mechanism have not been clearly elucidated. Here, we find that NCAPD3 is high -expression and up-regulates the levels of EZH2 and MALAT1 in PCa. In detail, high expression of NCAPD3 in-creases the levels of transcription factor STAT3 and E2F1 and recruits more STAT3 and E2F1 to the promoter of EZH2 gene and more STAT3 to the promoter of MALAT1 gene, and then results in the increasing expression of both EZH2 and MALAT1 in PCa cells. In vitro and in vivo functional characterization reveals that overexpression of NCAPD3 enhances the growth of PCa cells, while knockdown of NCAPD3 impairs the growth of PCa cells. Together, our data demonstrate that NCAPD3 is a tumor-promoting factor which enhances the progression of PCa by up-regulating EZH2 and MALAT1.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] SphK1 Promotes Cancer Progression through Activating JAK/STAT Pathway and Up-Regulating S1PR1 Expression in Colon Cancer Cells
    Long, Jianting
    Yao, Zhijia
    Sui, Yi
    Fang, Shi
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (02) : 254 - 260
  • [22] miR-137-3p Modulates the Progression of Prostate Cancer by Regulating the JNK3/EZH2 Axis
    Zang, Yachen
    Zhu, Jin
    Li, Qin
    Tu, Jian
    Li, Xiaoqing
    Hu, Rongkuan
    Yang, Dongrong
    ONCOTARGETS AND THERAPY, 2020, 13 : 7921 - 7932
  • [23] Umbelliferone Ameliorates Benign Prostatic Hyperplasia by Inhibiting Cell Proliferation and G1/S Phase Cell Cycle Progression through Regulation of STAT3/E2F1 Axis
    Kim, Hyo-Jung
    Jin, Bo-Ram
    An, Hyo-Jin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [24] The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1
    Su, Feng
    He, Wang
    Chen, Changhao
    Liu, Mo
    Liu, Hongwei
    Xue, Feiyuan
    Bi, Junming
    Xu, Dawei
    Zhao, Yue
    Huang, Jian
    Lin, Tianxin
    Jiang, Chun
    CELL DEATH & DISEASE, 2018, 9
  • [25] AIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1
    Tong, Z-T
    Wei, J-H
    Zhang, J-X
    Liang, C-Z
    Liao, B.
    Lu, J.
    Fan, S.
    Chen, Z-H
    Zhang, F.
    Ma, H-H
    Qian, W-C
    Kong, L-L
    Fang, Y.
    Chen, W.
    Xie, D.
    Luo, J-H
    BRITISH JOURNAL OF CANCER, 2013, 108 (07) : 1470 - 1479
  • [26] SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1
    Gu, Ye
    Wang, Xinling
    Liu, Hong
    Li, Guimei
    Yu, Weiping
    Ma, Qing
    ONCOLOGY REPORTS, 2018, 40 (04) : 1863 - 1874
  • [27] CHPF promotes gastric cancer tumorigenesis through the activation of E2F1
    Lin, Xiaolin
    Han, Ting
    Xia, Qing
    Cui, Jiujie
    Zhuo, Meng
    Liang, Yiyi
    Su, Wenyu
    Wang, Lisha
    Wang, Liwei
    Liu, Zebing
    Xiao, Xiuying
    CELL DEATH & DISEASE, 2021, 12 (10)
  • [28] Interplay of DNA methyltransferase 1 and EZH2 through inactivation of Stat3 contributes to β-elemene-inhibited growth of nasopharyngeal carcinoma cells
    Wu, JingJing
    Tang, Qing
    Yang, LiJuan
    Chen, YuQing
    Zheng, Fang
    Hann, Swei Sunny
    SCIENTIFIC REPORTS, 2017, 7
  • [29] circEZH2E2/E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression
    Su, Zhengzheng
    Zhang, Mengni
    Luo, Han
    Zhong, Jinjing
    Tan, Junya
    Xu, Yunyi
    Pan, Xiuyi
    Zeng, Hao
    Nie, Ling
    Xu, Miao
    Chen, Ni
    Chen, Xueqin
    Zhou, Qiao
    CANCER SCIENCE, 2023, 114 (04) : 1378 - 1395
  • [30] SKA3 promotes lung adenocarcinoma progression via the EGFR/E2F1/SKA3/integrin β1 signaling loop
    Zheng, Xiufen
    Sun, Zedong
    Wang, Shi
    Liu, Qibing
    Zhu, Biqing
    Ren, Zhijian
    Fan, Dingwei
    Zhang, Chunping
    Fu, Xinyin
    Jin, Yan
    Luo, Jing
    Wang, Jie
    Ren, Binhui
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2025,